Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Wheelden

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncotargets and Therapy|August 18, 2020
Clinical Evaluation of the Safety and Efficacy of Trifluridine/Tipiracil in the Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Evidence to DateMegan Wheelden, Nelson S Yee
Case Reports in Oncological Medicine|July 28, 2018
A Novel Adverse Event Associated with Olaparib Therapy in a Patient with Metastatic Breast CancerMegan Wheelden, Leah Cream, Jeffrey Sivik, et al.
Clinical Advances in Hematology & Oncology : H&O|October 2, 2024
Management options for node-positive muscle-invasive bladder cancerHyma V Polimera, Priyanka Bhatia, Megan Wheelden, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncotargets and Therapy|August 18, 2020
Clinical Evaluation of the Safety and Efficacy of Trifluridine/Tipiracil in the Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Evidence to DateMegan Wheelden, Nelson S Yee
Case Reports in Oncological Medicine|July 28, 2018
A Novel Adverse Event Associated with Olaparib Therapy in a Patient with Metastatic Breast CancerMegan Wheelden, Leah Cream, Jeffrey Sivik, et al.
Clinical Advances in Hematology & Oncology : H&O|October 2, 2024
Management options for node-positive muscle-invasive bladder cancerHyma V Polimera, Priyanka Bhatia, Megan Wheelden, et al.
Pageof 1